Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Disitamab Vedotin Plus Lenvatinib and PD-1 Inhibitors for Treating HER2-positive Advanced Biliary Tract Cancer

Peking Union Medical College Hospital · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
immune-checkpoint-inhibitors
biliary tract cancer, disitamab vedotin, lenvatinib, immune checkpoint inhibitors, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 897228
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.